Home > Resources > Whitepapers > A BUYER’S GUIDE FOR LOCALIZATION SERVICES:

A BUYER’S GUIDE FOR LOCALIZATION SERVICES:

August 21, 2019

Your localization partner is going to do a deep-dive into your business—so start by diving deep into theirs. Are they an industry-leader with 20 years of experience or a relative newcomer? Will they speak Samoan, Uzbek, or Swahili (and all your customers’ languages)? Can they deliver on-time and on-budget—every time? Ask how many languages they support. Find out whether their translator team comprises just linguists, or linguists and subject matter experts. Explore the backgrounds of their senior management team. Be nosey. Ask questions. Cyberstalk.

Spotlight

USV PRIVATE LIMITED

We are a 55 year old leading healthcare company which began as a joint venture with USV&P Inc. USA, a subsidiary of Revlon. Our product offering today includes Active Pharmaceutical Ingredients (APIs), Fixed Dosages Formulations (FDF), Peptides, Biosimilars and Injectables. These are manufactured in our cGMP compliant plants located in India. We market our products globally to 75 countries. In the financial year 2015-16, our total income was Rs 25,445 million. Our Indian business contributed 82% to the revenue and the rest was from export of APIs and Finished Dosages.

OTHER WHITEPAPERS

A Review of RNA Analysis using the Agilent AutomatedElectrophoresis Portfolio

whitePaper | July 15, 2022

Good-quality RNA is crucial to the success of many downstream applications, including qPCR, microarray analysis, and RNA sequencing. Agilent automated

Advanced Biopharmaceutical Manufacturing: An Evolution Underway

whitePaper | June 5, 2022

The past decade has seen a significant shift in the nature of the products being manufactured and sold by the innovative biopharmaceutical (biopharma) industry. The global biopharmaceutical portfolio of today reflects increased therapeutic competition, a greater prevalence of large molecule drugs, expansion in the number of personalized or targeted products, and a rise of treatments for many orphan diseases.